Meaning and Methodology of Fundamental Analysis (2025)

Dividend-paying stocks: return, risk, strategy

Balance sheet and income statement made clear 2025

What is a stock exchange? Operation, actors, examples

Stock Valuation 2025: A Beginner's Guide

Objective Corporation (ASX:OCL) share fundamentals, overview



Objective Corporation is an Australian software company founded in 1987, specializing in content and records management and regulatory workflow software for government and regulated industry sectors (e.g. defense institutions, military, etc.). The company is still led by founder Tony Walls today, who owns approximately 64.81% of the shares through the TBW Group holding company, one of the highest founder ownership ratios on the Aust

Objective Corporation (ASX:OCL) share fundamentals, overview



Objective Corporation is an Australian software company founded in 1987, specializing in content and records management and regulatory workflow software for government and regulated industry sectors (e.g. defense institutions, military,

Objective Corporation Stock Analysis – State Within State

What does the stock market report section contain?



The stock price has been in a steady decline ahead of the Computer Modelling Group's 2027 Q1 report, as the transformation of the mature oil company into a serial acquisition company is taking longer than expected. That's why it deserves a place in the "Reporting from the Stock Exchange" section, which is always an update on fundamental analysis. But what is it all about?



The column is a kind of compass for investors, helping them navigate

What does the stock market report section contain?



The stock price has been in a steady decline ahead of the Computer Modelling Group's 2027 Q1 report, as the transformation of the mature oil company into a serial acquisition company is taking longer than expected. That's why it deserves a place 

Computer Modeling Group 2027 Q1 - Turnarounds seldom turn?

The trust seeks to achieve its investment objective by holding a portfolio of the common stocks that are included in the index (the "Portfolio"), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the index.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Shock Top, Montauk Brewing, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point, Alpine, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Cruisies, Atwater Brewery, Hi-ball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Tilray: Schedule III Is Moving Forward, And The Stock Is Still Cheap

Tilray Brands Looks Ready For Another Large Short Squeeze Move

Tilray lifts annual cannabis cultivation capacity to about 275 metric tonnes

Insider trades: Microsoft, Meta, Pfizer among notable names

Tilray Remains Undervalued As Revenue Reaches Record Highs

Tilray Brands climbs 8%, extending prior day's gains

Tilray Q4: Dilution Outweighs Progress

Tilray projects $68M-$75M adjusted EBITDA in fiscal 2027 as it targets margin expansion

Tilray Brands, Inc. (TLRY) Q4 2026 Earnings Call Transcript

Tilray rises despite missing FQ4 bottom line on strong FY27 EBITDA growth guidance

Earnings Snapshot: Tilray Brands Q4 revenue jumps 25%; guides FY27 EBITDA to $75M

Tilray Non-GAAP EPS of $0.11 misses by $0.10, revenue of $281.71M beats by $35.41M

Tilray Earnings Preview: What to expect

Tilray launches THC pouch-based product Zonna

Tilray May Benefit From Rescheduling Of Cannabis In The US

Tilray acquires digital health platform HelloMD

Tilray Looks Cheap On The Surface, But Shareholders Still Need Proof

Insider trades: Morgan Stanley, Uber, Adobe among notable names

Cannabis selloff hits CRON, ACB, CGC, TLRY, OGI as reclassification seen limited

Wall Street Lunch: Cannabis Stocks Fly High On DEA Rescheduling Move

Pot stocks rise as DOJ reschedules marijuana as a less-dangerous drug

Quant snapshot on cannabis names as Trump plans reclassification

Tilray announces $180M equity offering; debt-for-equity deals to issue 1.9M shares

Tilray Has Strong Synergies, But Sector Remains Weak

Tilray Brands Is Looking Better

Tilray rebounds as Roth Capital upgrades to Buy after Q3 results

Tilray reaffirms FY2026 adjusted EBITDA of $62M-$72M as BrewDog deal targets $1.2B annualized revenue run rate

Tilray Brands, Inc. (TLRY) Q3 2026 Earnings Call Transcript

Tilray posts Q3 revenue beat on international cannabis sales

Tilray Brands in charts: FQ3 segmental revenues see double-digit increase Y/Y, except alcohol slumps 24%

revenue-canada

Adult-use Cannabis Gross Revenue (TTM) Canada as of 2021-05

Szabad Felhasználású Kannabisz Árbevétel Kanadában (TTM) 2021-05-ig bezárólag

ebitda

Adjusted EBITDA ($M)

Módosított EBITDA ($M)

Segment definitions

revenue-by-segment

Revenue by Segment (% - FY2021)

Árbevétel Szegmensenként (% - FY2021)

Accounts payable

Total current assets

Cash

Short/Current long term debt

Goodwill

Intangible assets

Net tangible assets

Property, plant and equipment

Net receivables

Shareholder's equity

Total assets

Total current liabilities

Total liabilities

Balance Sheet

Capital expenditures (TTM)

Operating cash flow (TTM)

Dividends paid (TTM)

Free cash flow (TTM)

Cash flow

DGR 10 years

DGR 15 years

DGR 3 years

DGR 5 years

DGR MR

DGR TTM

EPS growth (5y forward)

EPS growth (5y)

Time since last change announced

Dividend growth

Average yield

Yield as % of max yield

Discount to avg yield

Dividend per share

Dividend yield

Payout frequency

Maximum yield

Minimum yield

Upside potential

Dividend yield - 5y

Avg time to new high

Avg drop from high

Max time to new high

Highest price drop

Date of highest drop

Current price drop from All-time high

Downside potential

CCC status

Years of growth

EPS (1y forward)

EPS (TTM)

Ex-div date

Cash Return on Invested Capital

Return on Assets

Return on Equity

Return on Invested Capital

Financial returns

Gross profit (TTM)

Net income (TTM)

Operating income (TTM)

Revenue (TTM)

Income statement

Gross margin (TTM)

Operating margin (TTM)

Profit margin (TTM)

Margins

Average

Forward

Payout ratio

FCF per share (TTM)

Current share count

Per share

Current yield distribution

Yield at 0% (Max)

Yield at 10%

Yield at 100% (Min)

Yield at 20%

Yield at 50% (Median)

Yield at 80%

Yield at 90%

Yield distribution (inverse percentile) - 5y

All-time high

1y analyst estimate

Beta

Price at close

Daily high

Daily low

Open

Daily Volume

Next earnings date

Stock chart

EV to Sales

Price to Book

Price to Sales

Valuation (Sales/Book Value)

EV to EBITDA

Trailing P/E

Price to EBITDA

Price to FCF

Price to OCF

Valuation Ratios

TLRY

Objective Corporation Stock Analysis – State Within State

Business insight

Meaning and Methodology of Fundamental Analysis (2025)

Adult-use Cannabis Gross Revenue (TTM) Canada as of 2021-05

Adjusted EBITDA ($M)

Revenue by Segment (% - FY2021)